Results 241 to 250 of about 1,413,386 (299)

Cost-effectiveness analysis of the use of faricimab in diabetic macular edema in China. [PDF]

J Comp Eff Res
Shi F, Tan S, Shu Y, Liu T, Xia Y, Buehrer C, Han S.   +6 more
europepmc   +1 more source

Cost-Effectiveness of Highly Effective Glucose-Lowering Agents: Do Current Practices Optimize Clinical and Economic Outcomes? [PDF]

Diabetes Ther
Hoog M, Minghetti A, Valentine WJ.
europepmc   +1 more source

The impact of hearing loss on annual incident age-associated dementia cases and quality of life in the United States. [PDF]

J Gerontol A Biol Sci Med Sci
Borre ED, Deleger JN, Dillard LK, Pavon JM, Shah SJ, Dubno JR, Smith SL, Freedberg KA, Francis HW, Ritchie CS, Sanders Schmidler GD, Hyle EP.   +11 more
europepmc   +1 more source

Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis: The BE RADIANT Randomized Clinical Trial With Open-Label Extension.

JAMA Dermatol
Augustin M, Feldman SR, Warren RB, Armstrong A, Vender R, López-Ferrer A, Dawe WH, Lambert J, Szilagyi B, Hoepken B, Warham R, Gottlieb AB.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Quality-Adjusted Life Years

Practical Neurology, 2008
Many health systems now use cost-effectiveness analysis to decide which interventions and programmes to fund. A key issue for such decision making is how to measure health outcomes from interventions to reflect changes in both health-related quality of life and life expectancy.
Yolanda, Bravo Vergel, Mark, Sculpher
openaire   +3 more sources

Utilities and Quality-Adjusted Life Years

International Journal of Technology Assessment in Health Care, 1989
Utilities and quality-adjusted life years (QALYs) are reviewed, with particular focus on their use in technology assessment. This article provides a broad overview and perspective on these two techniques and their interrelationship, with reference to other sources for details of implementation.
G W, Torrance, D, Feeny
openaire   +2 more sources

Quality-adjusted life-years

Abstract The concept of quality-adjusted life years (QALY) is explained, with the approaches to measuring and problems with QALYs highlighted.
Phil Ambery, Adrian Kilcoyne, Daniel O’Connor   +2 more
openaire   +2 more sources

QUALITY-ADJUSTED LIFE-YEARS

The Lancet, 1987
Alan Williams, RogerW Evans, MichaelF Drummond   +2 more
  +6 more sources

Quality‐adjusted life years: origins, measurements, applications, objections

Australian Journal of Public Health, 1993
Abstract: Quality‐adjusted life years or QALYs are used to combine, in a single measure, information about the quantity and quality of life produced by a health intervention. They have been used as outcome measures in clinical trials and in cost‐effectiveness analyses. This paper describes how QALYs are assessed and how they are used.
Schwartz, Steven, Richardson, Jeffrey, Glasziou, Paul P.   +2 more
openaire   +3 more sources

Not all “quality-adjusted life years” are equal

Journal of Clinical Epidemiology, 2007
There is evidence that utility elicitation methods used in the calculation of quality-adjusted life years (QALYs) yield different results. It is not clear how these differences impact economic evaluations.Using a mathematical model incorporating data on efficacy, costs, and utility values, we simulated the experiences of 100,000 hypothetical rheumatoid
C A, Marra, S A, Marion, D P, Guh, M, Najafzadeh, F, Wolfe, J M, Esdaile, A E, Clarke, M A, Gignac, A H, Anis   +8 more
openaire   +2 more sources